We are live on ! Find out more
VBIV

VBI Vaccines, Inc. New Common Stock (Canada)
VBIV

Delisted

VBIV was delisted on the 7th of August, 2024.

Back to rankings

5 hedge funds and large institutions have $360K invested in VBI Vaccines, Inc. New Common Stock (Canada) in 2014 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% less capital invested

Capital invested by funds: $361K → $360K (-$1K)

29% less funds holding

Funds holding: 7 → 5 (-2)

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

Holders
5
Holders Change
-2
Holders Change %
-28.57%
% of All Funds
0.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$10.4K

Top Sellers

Rank Fund Capital Flow
1
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
-$47K
2
U
UBS
Switzerland
-$4K
3
TRCT
Tower Research Capital (TRC)
New York
-$1K

VBIV Hedge Fund Activity: Q1 2014 in Review

5 of the 3,475 institutional investors tracked by Wall St. Rank reported a position in VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) for Q1 2014, worth a combined $360K — down 0.28% from $361K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of VBIV and 1 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $10.4K. The largest seller was Hudson Bay Capital Management, exiting entirely with an estimated $47K sold.

  • 5 institutional investors held VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) as of Q1 2014, down from 7 in Q4 2013.
  • Funds reported $360K of VBI Vaccines, Inc. New Common Stock (Canada) stock for Q1 2014, down 0.28% quarter-over-quarter.
  • 1 fund opened new VBI Vaccines, Inc. New Common Stock (Canada) positions in Q1 2014 and 3 closed out, a net change of -2 holders.
  • The largest VBI Vaccines, Inc. New Common Stock (Canada) buyer in Q1 2014 was Citadel Advisors, an estimated $10.4K added.
  • The largest VBI Vaccines, Inc. New Common Stock (Canada) seller in Q1 2014 was Hudson Bay Capital Management, an estimated $47K sold.

Based on aggregated 13F filings for Q1 2014.